BUY Alivus Life Sciences Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)7 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·30 Jun · today
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Alivus Life Sciences
- BUY — Siddharth Rai Mangala9 Sept 2026 · ~2 weeks · target ₹1,530 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities30 Jun 2026 · ~3 months · target ₹1,315 · Target hit
- BUY — ICICI Securities15 May 2026 · ~1 year · target ₹1,235 · Target hit
- BUY — ICICI Securities23 Jan 2026 · ~1 year · target ₹1,190 · Target hit
- BUY — ICICI Securities26 Aug 2024 · ~1 year · target ₹1,295 · Target hit
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

